Republic Healthcare Limited filed its Monthly Return for Equity Issuer for the period ended 30 April 2026, showing no changes in either authorised or issued share capital during the month.

Authorised Share Capital • Authorised share capital remained at HKD 100.00 million, corresponding to 10.00 billion ordinary shares with a par value of HKD 0.01 each. • No increases or reductions were recorded.

Issued Share Capital and Public Float • Issued share count stayed unchanged at 624.00 million ordinary shares; the company continues to hold zero treasury shares. • Management confirmed that the minimum 25 percent public-float requirement was satisfied as of 30 April 2026.

Share Option Scheme Activity • The option scheme approved on 18 May 2018 reported no option exercises, grants, lapses, or cancellations, resulting in no new shares issued and no transfer of treasury shares.

Other Capital Instruments • The company reported no warrants, convertible securities, or other equity-linked agreements outstanding or transacted during the month.

Regulatory Compliance • Director Tan Cher Sen Alan affirmed that all share-related matters have complied with Hong Kong Listing Rules and applicable legal requirements.

With capital structure unchanged and regulatory confirmations in place, Republic HC ends April 2026 with a stable equity position and full compliance status.